Qi Cui, AGS 2021: The GLP-1R
Agonist NLY01 Reduces Neuroinflammation and Protects against RGC Loss in a
Preclinical Glaucoma Model
Published Online: March 5th 2021
We were delighted
to catch up with Dr Qi Cui (Scheie Eye Institute, University of Pennsylvania,
PA, USA), who told us about her research on the GLP-1R agonist NLY01 and the
next steps for clinical development.
Questions
Speaker
Disclosure: Qi Cui discloses the following: Patent (pending): Penn Center
for Innovation; Sponsored Research: Neuraly, Inc., NIH/NEI K08EY029765.
Support: Interview
and filming supported by Touch Medical Media Ltd.
Filmed in coverage
of AGS 2021.